NCT05992298

Brief Summary

The goal of the current project is to explore and develop the technical feasibility of non-invasive imaging of the human musculoskeletal system and head with the first 7T MR scanner with a CE mark to identify areas where the higher field promises significant benefits in qualitative image quality. For a subset of the planned exams, state-of-the art 7T or 3T images will be used as standard of reference to comparatively gauge the qualitative image quality of the investigational 7T images.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
780

participants targeted

Target at P75+ for not_applicable

Timeline
23mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Aug 2023Feb 2028

First Submitted

Initial submission to the registry

July 18, 2023

Completed
20 days until next milestone

Study Start

First participant enrolled

August 7, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 15, 2023

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2028

Last Updated

October 2, 2025

Status Verified

October 1, 2025

Enrollment Period

4.6 years

First QC Date

July 18, 2023

Last Update Submit

October 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Qualitative image quality of 7 T MRI

    Current-day feasibility of various types of MR examinations of the human musculoskeletal system. The primary outcomes of small consistent series of the study are visual gradings and qualitative measures of image quality. Image quality is rated by independent readers using Likert scales.

    through study completion, an average of 1 year

Study Arms (1)

7 T MRI

EXPERIMENTAL
Other: 7 T MRI vs 3 T MRI

Interventions

Adult healthy and patient volunteers will undergo a ca. 1 hour examination of non-invasive magnetic-resonance imaging at 7T, and, if appropriate, a closely matching examination at 3T as a standard of reference.

7 T MRI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consent to undergo a 7T (and, if appropriate a comparative 3T) MRI exam.
  • For some of the consistent small series: presence of a specific condition of the musculoskeletal system or of the head. This can include traumatic or degenerative changes, e.g., of tendons, cartilage, muscle, peripheral nerves, ligaments, and bones, or in the brain, as well as focal lesions, e.g., tumors.

You may not qualify if:

  • Contraindications to undergo a MRI examination at a field strength of 7 Tesla or at 3 Tesla.
  • Irregular anatomy and/or tissue properties
  • Inability to consent - for any reason.
  • Body mass above 200 kg.
  • Body mass below 30 kg.
  • Women: pregnancy.
  • Age below 18.
  • Known or suspected non-compliance, drug or alcohol abuse.
  • Inability to follow the procedures of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balgrist University Hospital

Zurich, Canton of Zurich, 8008, Switzerland

RECRUITING

Study Officials

  • Reto Sutter, Prof.

    Balgrist University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. med. Reto Sutter

Study Record Dates

First Submitted

July 18, 2023

First Posted

August 15, 2023

Study Start

August 7, 2023

Primary Completion (Estimated)

February 29, 2028

Study Completion (Estimated)

February 29, 2028

Last Updated

October 2, 2025

Record last verified: 2025-10

Locations